Concomitant aberrant methylation of p15 and MGMT genes in acute myeloid leukemia: association with a particular immunophenotype of blast cells

Autor: Nada Suvajdžić, Nada Kraguljac Kurtovic, Koviljka Krtolica, Milena Krajnović, Jelica Jovanovic, Milica Colovic, Andrija Bogdanovic, Bogomir Dimitrijević
Rok vydání: 2012
Předmět:
Male
Cancer Research
Myeloid
CD34
Kaplan-Meier Estimate
Polymerase Chain Reaction
0302 clinical medicine
Immunophenotyping
Promoter Regions
Genetic

DNA Modification Methylases
0303 health sciences
Methylation profile
Hematology
biology
Myeloid leukemia
General Medicine
Methylation
Middle Aged
Flow Cytometry
Prognosis
3. Good health
Leukemia
Myeloid
Acute

medicine.anatomical_structure
Oncology
030220 oncology & carcinogenesis
DNA methylation
Female
MGMT
Immunophenotype
Adult
medicine.medical_specialty
Young Adult
03 medical and health sciences
Internal medicine
Biomarkers
Tumor

medicine
Humans
neoplasms
Aged
Cyclin-Dependent Kinase Inhibitor p15
030304 developmental biology
Acute myeloid leukemia
CD117
Tumor Suppressor Proteins
DNA Methylation
digestive system diseases
DNA Repair Enzymes
Immunology
biology.protein
Cancer research
p15(INK4B)
Zdroj: Medical Oncology
ISSN: 1559-131X
1357-0560
Popis: In this study, methylation-specific polymerase chain reaction (MS-PCR) was used to define the methylation status of the target promoter sequences of p15 and MGMT genes in the group of 21 adult patients with acute myeloid leukemia (AML). The incidence of aberrant hypermethylation of p15 gene (71 %) was higher comparing to MGMT gene (33 %), whereas concomitant methylation of both genes had 24 % of the patients. Although the incidence of cytogenetic abnormalities between the groups with a different methylation status of p15 and/or MGMT genes was not significantly different, we observed general trend of clustering of abnormalities with adverse prognosis into groups with concomitant hypermethylation of both genes and only p15 gene. Also, we showed that AML patients with concomitant methylation of p15/MGMT genes had a higher proportion of leukemic blast cells characterized with specific expression of individual leukocyte surface antigens (CD117(+)/CD7(+)/CD34(+)/CD15(-)), indicating leukemic cells as early myeloid progenitors. Although we could not prove that hypermethylation of p15 and/or MGMT genes is predictive parameter for response to therapy and overall survival, we noticed that AML patients with comethylated p15/MGMT genes or methylated p15 gene exhibited a higher frequency of early death, lower frequency of complete remissions as well as a trend for shorter overall survival. Assessing of the methylation status of p15 and MGMT genes may allow stratification of patients with AML into distinct groups with potentially different prognosis.
Databáze: OpenAIRE